For: | Chen JL, Guo L, Wu ZY, He K, Li H, Yang C, Han YW. Prognostic value of circulating tumor cells combined with neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(2): 372-385 [PMID: 38425405 DOI: 10.4251/wjgo.v16.i2.372] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v16/i2/372.htm |
Number | Citing Articles |
1 |
Erfan Taherifard, Krystal Tran, Ali Saeed, Jehad Amer Yasin, Anwaar Saeed. Biomarkers for Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma: A Comprehensive Review. Diagnostics 2024; 14(18): 2054 doi: 10.3390/diagnostics14182054
|
2 |
Marco Maria Pascale, Francesco Frongillo, Pierangelo Vasta, Giuseppe Massimiani, Erida Nure, Salvatore Agnes. Significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio as prognostic predictors after liver transplantation. World Journal of Transplantation 2025; 15(2): 100157 doi: 10.5500/wjt.v15.i2.100157
|
3 |
Lin Xu, Xu Che. Sorafenib combined with tarexib for first-line treatment of unresectable hepatocellular carcinoma and its predictive role and correlation with PD-L1 CTCs. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1478596
|
4 |
Jaeho Park, Yi-Te Lee, Vatche G. Agopian, Jessica S Liu, Ekaterina K. Koltsova, Sungyong You, Yazhen Zhu, Hsian-Rong Tseng, Ju Dong Yang. Liquid biopsy in hepatocellular carcinoma: Challenges, advances, and clinical implications. Clinical and Molecular Hepatology 2025; 31(Suppl): S255 doi: 10.3350/cmh.2024.0541
|
5 |
Atsushi Ono, C. Nelson Hayes, Ryoichi Miura, Tomokazu Kawaoka, Masataka Tsuge, Shiro Oka. Noninvasive prediction of the clinical benefit of immunotherapy in hepatocellular carcinoma. Journal of Gastroenterology 2025; doi: 10.1007/s00535-025-02251-x
|